Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CANNABIDIOL
- Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions
- Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts
- CBD for Breast Cancer Primary Tumors
- Cannabidiol Oil Extract for Prevention of Postoperative Nausea and Vomiting
- CBD Oil-Scar Healing Study
- Cannabidiol Effects on Fear Extinction in Social Phobia
- Topical Cannabidiol for Treating Carpal Tunnel Syndrome
- Longitudinal Outpatient Treatment for Cannabis Use Disorder
- Modulation of THC Effects by CBD: a Dose-ranging Study
- Therapy With Paravertebral Oxygen-ozone Injections and Topical Cannabidiol and β-Caryophyllene Patch in Neck Pain
- The Effect of Cannabidiol in Learning and Memory of Adults
- Behavioral Pharmacology of Cannabis in Older Adults
- Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy
- Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritis
- SCORE Emerging Adult Cannabis Use & Stress
- Cannabidiol for Bipolar Depression (CBD-BD)
- Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: a Phase ii Trial
- Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
- Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia
- Role of CBD in Improving Alexithymia
- Cannabidiol to Reduce Anxiety Reactivity: A Randomized Controlled Trial in Social Anxiety Disorder
- CBD for Individuals at Risk for Alzheimer's Disease
- Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
- Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA
- CANnabinoids in Pediatric ONCology
- A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
- The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol
- The Effects of CBD Isolate on Menstrual-Related Symptoms
- Safety, Tolerability, and Efficacy of RLS103 in a Clinical Model of Photosensitive Epilepsy
- Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
- Cannabidiol for the Treatment of Pelvic Pain in Endometriosis (DREAMLAND)
- Evaluation of the Efficacy of CANNABIDIOL on the Pruritus in Children With Hereditary Epidermolysis Bullosa
- Investigating the Effects of Cannabidiol on Social Anxiety Disorder
- Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients.
- Life's End Benefits of Cannabidiol and Tetrahydrocannabinol
- Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
- Effects of Cannabidiol (CBD) on Resting-state Electroencephalography (EEG) and Neuropathic Pain Severity in People With Spinal Cord Injury (SCI)
- Alcohol Use Disorder and Cannabidiol
- Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
- Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
- Fenfluramine for Adult Dravet Patients
- Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
- Sativex® and Gentamicin for Optimized Pharmagological Treatment in Older Patients (CanPan)
- Impact of CardiolRxTM on Recurrent Pericarditis
- Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
- The Pharmacodynamics of Cannabinoid-Caffeine Combinations
- Cannabidiol vs Opioid for Photorefractive Keratectomy Pain Control
- Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
- Oral Cannabidiol for Tobacco Cessation
- MEDical CANnabis for Improving Symptoms During Severe DEMentia Disorders in Long-term Care Facility in Geneva
- Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)
- A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users
- Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
- A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
- The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence
- Opioid-Sparing Effect of Oral Cannabinoids
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
- Cannabis for Chronic Headaches in Adolescents: the CAN-CHA Trial
- Epidiolex® for Anxiety in Pediatric Epilepsy
- A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
- Cannabidiol in Youth Alcohol Use Disorder
- Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients
- Reducing Pain and Opioid Use With CBD
- Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
- Cannabidiol Effects on Learning and Anxiety
- CBD (Cannabidiol)/THC (Tetrahydrocannabinol) Solution as a Pharmacological Strategy for Patients With Fibromyalgia
- Clinical Trial of Nabilone for Aggression in Adults With Intellectual and Developmental Disabilities
- Pharmacokinetic Investigation of BSPG Laboratories (BSPG) Cannabidiol in Healthy Participants
- Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- Safety and Efficacy of Cannabidiol (CBD) for Symptoms of PTSD in Adults
- Effectiveness of Cannabidiol vs. Narcotics for Post Operative Pain Control in Elective Shoulder Arthroscopic Surgery
- Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
- Evaluation of an Oral Cannabidiol (CBD)-Terpene Formulation on Sleep Physiology in Participants With Insomnia
- Cannabidiol Effects on Cardiovascular System and Exercise Responses
- Treatment With Cannabis Oil Containing CBD Only or 20:1 CBD:THC vs. Placebo of Persons With ADHD
- The Effects of Medical Cannabis in Children With Autistic Spectrum Disorder
- HEMP: CBD-induced Biomarkers of Inflammation Reduction in People Living With HIV at the Single Cell Level
- Impact of CardiolRx on Myocardial Recovery in Acute Myocarditis
- Topical CBD for Musculoskeletal Pain
- Reducing the Harmful Effects of Cannabis Use: Finding the Optimal CBD:THC Ratio
- Cannabidiol for Reducing Drinking in Alcohol Use Disorder
- Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome
- Evaluation of the Interactions of Cannabidiol (CBD) With Morphine
- Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder in Military Veterans
- A Phase 2/3 Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader-Willi Syndrome
- CBD for Sleep in People With HIV
- Cannabis as a Complementary Treatment in Multiple Sclerosis
- Safety of Cannabidiol Given to Subject With Methadone or Buprenorphine
- Evaluation of Oral THC and CBD in Men and Women
- Cannabidiol for Reduction of Brain Neuroinflammation
- The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A
- Topical Cannabidiol Cream and Post-exercise Recovery
- Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
- Evaluation of Smoked THC and CBD in Men and Women
- Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulation
- Investigation of the Pharmacokinetic Profile of Nanoemulsion CBD
- The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment
- Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis
- Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
- Comparison of JW-100 and EUCRISA®
- Cannabidiol (CBD) in Adults With ASD
- Evaluation of a Specific Transdermal Cannabidiol Product for Chronic Musculoskeletal Joint Pain.
- Feasibility of Cannabidiol for the Treatment of Long COVID
- Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
- Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg vs Placebo as Adjuvant Treatment in Chronic Migraine -
- Cannabidiol on Reward- and Stress-related Neurocognitive Processes in Individuals With Opioid Use Disorder
- Epidiolex in Obsessive Compulsive Disorder
- Clinical Study of Cannabidiol in Children and Adolescents With Fragile X Syndrome
- Therapeutic Response of Cannabidiol in Rheumatoid Arthritis
- Cannabis Use, Cognition, and the Endocannabinoid System in HIV
- Role of CBD in Regulating Meal Time Anxiety in Anorexia Nervosa
- CBD for the Treatment of Alcohol Use Disorder
- THC + CBD and Memory Study
- Do Adolescents and Adults Differ in Their Acute Response to Cannabis?
- Androgenetic Alopecia Treatment Using Varin and Cannabidiol Rich Topical Hemp Oil: A Case Series
- Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation
- Effects of Cannabidiol (CBD) on the Brain
- Evaluation of the Effectiveness of Cannabidiol in Treating Severe Behavioural Problems in Children and Adolescents With Intellectual Disability
- Effect of Cannabinoids on Pain in Fabry Disease Patients
- Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement
- NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
- Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration
- Hippocampal Response to Acute Oral Doses of CBD During an fMRI Memory Task
- Sex Differences in Neural Response to Cannabidiol
- Methodology for Developing an Occlusal Appliance With CBD Active Carrier
- CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
- CBD for Chronic Radiculopathy on Chronic Opioid Therapy (COT)
- Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias
- Cannabidiol for Bilateral Total Knee Arthroplasty
- Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder
- The Pharmacokinetics and Pharmacodynamics of Hemp-based Topical Cannabinoid Products
- Cannabidiol for Treatment Resistant Depression
- Cannabidiol and Autonomic Function at Rest
- Cannabidiol Treatment for Severe and Critical Coronavirus (COVID-19) Pulmonary Infection
- The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management
- Cannabidiol for Fibromyalgia (The CANNFIB Trial)
- Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
- Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise
- Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet
- CBD for Dental Pain
- Full-spectrum Medical Cannabis for Treatment of Spasticity in Patients With Severe Forms of Cerebral Palsy
- Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee
- Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors
- The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial
- Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome
- Topical CBD in Joint Arthritis
- Comparative Analysis of the Effectiveness of the Use of Nimesulide and CBD Oil in Patients With Pain in the Preauricular Region Due to the Pain-dysfunctional Syndrome of the Temporomandibular Joint.
- Efficacy of Cannabidiol in Knee Osteoarthritis
- Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Study
- Cannabidiol and CES1 Interactions in Healthy Subjects
- A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population
- The Effects of Cannabidiol on the Driving Ability of Healthy Adults
- Cannabidiol in Opioid Use Disorder and Chronic Pain
- Efficacy of a Controlled Short-term Trial of Cannabidiol (CBD) Ingestion on Reducing Symptomatic Response and Facilitating Recovery After Induced Muscle Injury
- The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy
- Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy
- Repeated Cannabis Administration on Experimental Pain and Abuse Liability
- Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
- Cannabidiol and Management of Endometriosis Pain
- CASCADE: CAnnabidiol Study in Children With Autism Spectrum DisordEr
- Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
- Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19
- Safety, Pharmacokinetics, and Exploratory Efficacy Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) Compared With Standard of Care Antiepileptic Therapy, in Patients Age 1 Month to <12 Months of Age With Tuberous Sclerosis Complex Who
- RCT of CBD for Anxiety in Advanced Breast Cancer
- CANnabiDiol for CoviD-19 pATiEnts With Mild to Moderate Symptoms
- Safety and Pharmacokinetics of Vaped Cannabis in Healthy Volunteers
- Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome
- Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) Patients
- Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
- Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm
- Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis
- Study of Safety and Efficacy of MGCND00EP1 as an Add on Treatment in Children and Adolescents With Resistant Epilepsies
- CBD-Microglia PET Study
- Effect of Hemp-CBD on Patients With CIPN
- Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
- A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
- Efficacy of Inhaled Cannabis for Acute Migraine Treatment
- The CBD-IC Randomized Controlled Trial: Evaluation of Hemp Cannabidiol SuppositoRies for Pain and Urinary SymptOms in INterstitial Cystitis (CHRONIC)
- Cannabis Effects on Electroencephalography
- A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
- The Pharmacokinetic and Pharmacodynamic Effects of Oral Cannabidiol (CBD) Under Acute and Chronic Exposure Conditions
- CBD Cannabis Extract: Pharmacokinetic Studies
- Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
- Cannabidiol for Anxiety
- An Open-label Extension Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- Phase II Clinical Trial, Use of KL16-012 in Women With Fibromyalgia Refractary to Conventional Treatment.
- Oral Cannabidiol for Opioid Withdrawal
- Effects of Cannabis on Cognition and Endocannabinoid Levels in Bipolar Disorder Patients and Healthy Volunteers
- Cannabis Impairment Detection Application (CIDA)
- Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products
- Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal
- Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder
- Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain
- Cannabidiol Use to Reduce Cravings in Individuals With Opioid Use Disorder on Buprenorphine
- Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
- A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
- Cannabidiol for Treatment of Recent-onset Psychosis With Comorbid Cannabis Use
- Effect of Topical CBD Cream for Degenerative Hallux Disorders
- The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy
- CHI-902 for Treatment of Social Anxiety Disorder
- Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Alzheimer's Dementia
- Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults
- A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn's Disease Patients
- Mechanisms of CBD for Chronic Pain
- A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol
- Cannabidiol, Morphine, Pain
- Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
- Sublingual Cannabidiol for Chronic Pain
- Cannabis for the Prophylactic Treatment of Migraine
- Cannabis For Cancer-Related Symptoms
- Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia
- Comparison of Safety, Tolerability and Pharmacokinetics of Medical Grade Cannabis (MGC) Orally Disintegrating Tablets With Buccal Sativex®, in Healthy Adult Volunteers
- Cannabidiol for Alcohol Use Disorder
- Cannabidiol for ASD Open Trial
- Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
- Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis
- Bioequivalence Assessment of Cannabidiol (CBD) Administrated in Oral Formulations
- Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
- An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Behavioral and Physiological Effects of THC and CBD
- Cannabinoids vs. Placebo on Persistent Post-surgical Pain Following TKA: A Pilot RCT
- Exploratory Dose Ranging Study Assessing APH-1501 for the Treatment of Opioid Addiction
- Cannabis Extract in Refractory Epilepsy Study
- Trial of Cannabis for Essential Tremor
- Open Label Extension to Assess the Long-Term Safety and Tolerability of ZYN002 in Children and Adolescents With FXS
- Cannabidiol as Adjunctive Treatment for Opioid Use Disorder
- CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
- COPE: Cannabinoids to Obviate Pain Experiment After Knee Replacement
- Cannabis Oil for Pain in Parkinson's Disease
- Cannabis Oil for Chronic Non-Cancer Pain Treatment
- Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C
- Clinical Study Of caNNabidiol in childrEn and adolesCenTs With Fragile X (CONNECT-FX)
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
- A Study of Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease
- Cannabinoids in PLWHIV on Effective ART
- Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
- Shifting Brain Excitation-Inhibition Balance in Autism Spectrum Disorder
- TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma
- Cannabidiol and Prolonged Exposure
- Cannabidiol - an in Vivo Innovative Drug Delivery Study
- Cannabidiol Usage as an Adjunct Therapy for Crohn's Disease
- A Study to Assess the Safety and Tolerability of ZX008 in Children and Young Adults With Dravet Syndrome or Lennox Gastaut Syndrome Currently Taking Cannabidiol
- A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome
- A Study to Assess the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile Spasms
- Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam
- Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
- Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
- Cannabidiol as an Adjunctive Treatment for Bipolar Depression
- Effects of Marijuana on Symptoms of OCD
- Effects of Cannabidiol in Alcohol Use Disorder
- Cannabidiol as a Treatment for AUD Comorbid With PTSD
- Safety and Efficacy of Cannabis in Tourette Syndrome
- Tolerability of Cannabis in Patients Receiving Concurrent Chemoradiation for Glioblastoma
- Marijuana in Combination With Opioids in Palliative and Hospice Patients
- Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
- The Role of SAtivex® in Robotic-Rehabilitation
- The Effects of Different Medical Marijuana Strains on Motor and Cognitive Function in People With Multiple Sclerosis
- The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol
- Cannabidiol Pharmacotherapy for Adults With Cannabis Use Disorder
- Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain
- The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients
- Cannabidiol in Children With Refractory Epileptic Encephalopathy
- A Study to Evaluate the Safety, Tolerability and Efficacy of Oral Administration of PTL101 (Cannabidiol) as an Adjunctive Treatment for Pediatric Intractable Epilepsy
- Cannabinoid Therapy for Pediatric Epilepsy
- Cannabinoids for Behavioral Problems in Children With ASD
- Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)
- Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms (GWPCARE7)
- Cannabioids as a New Intervention for Amphetamine Dependence
- Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia
- Enhancing Recovery in Early Schizophrenia
- Cannabidiol and Emotional Stimuli
- Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome
- A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease
- The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy
- A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy
- Pilot Study of the Safety and Efficacy of Four Different Potencies of Smoked Marijuana in 76 Veterans With PTSD
- Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
- University of Alabama at Birmingham (UAB) Adult CBD Program
- University of Alabama at Birmingham (UAB) Pediatric CBD Program
- Investigation of Cannabis for Chronic Pain and Palliative Care
- Investigation of Cannabis for Pain and Inflammation in Lung Cancer
- Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
- An Open-label Extension Trial to Investigate Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
- A Study of Possible Drug-drug Interactions Between Stiripentol or Valproate and Cannabidiol in Patients With Epilepsy
- A Randomized Controlled Trial to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
- An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
- Cannabidiol and Cocaine Craving/Dependence
- Cannabidiol for Pediatric Epilepsy (Compassionate Use)
- Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms
- Sublingual Cannabidiol for Anxiety
- A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
- An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
- Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans
- Cannabidiol Treatment in Patients With Early Psychosis
- Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study
- Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids
- Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease
- Treatment of Drug Resistant Epilepsy
- Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
- Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
- A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function.
- Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee
- Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders
- Cannabidiol Oral Solution as an Adjunctive Treatment for Treatment-resistant Seizure Disorder
- Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
- Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Lennox-Gastaut Syndrome
- Effects of THC and CBD on Human Episodic Memory Function
- Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
- Anesthetic Premedication With a Cannabis Extract (Cannapremed)
- A Study: Pure CBD as Single-agent for Solid Tumor.
- A Randomised, Open-label, Three-way Crossover Study to Assess the Pharmacokinetics and Safety of Single Doses of Four Sprays of Sativex® in a Range of Oral pH Environments in Healthy Subjects
- GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome
- A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
- GWPCARE5 - An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
- Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
- The Role of the Endocannabinoid System in Sweet Taste Intensity and Liking
- Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
- A Dose-ranging Pharmacokinetics and Safety Study of GWP42003-P in Children With Dravet Syndrome (GWPCARE1)
- A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol as a Treatment for Acutely Ill Schizophrenic Patients
- Cannabidiol (CBD) for the Management of Cannabis Withdrawal: A Phase II Proof of Concept Study
- Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
- Cannabidiol: a Novel Intervention for Cannabis Use Problems?
- A Study of GWP42003 as Adjunctive Therapy in the First Line Treatment of Schizophrenia or Related Psychotic Disorder
- A Pharmacokinetic Study of Single Doses of Sativex in Treatment-induced Mucositis
- Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)
- Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients
- Laboratory Study of Cannabidiol on the Effects of Smoked Marijuana
- Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease
- Fixed or Self-Titrated Dosages of Sativex on Cannabis Users
- Sativex and Behavioral-relapse Prevention Strategy in Cannabis Dependence
- An Study to Investigate the Efficacy of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
- An Investigation of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis Patients
- A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis
- Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans
- Safety and Efficacy of Cannabidiol for Grade I/II Acute Graft Versus Host Disease (GVHD) After Allogeneic Stem Cell Transplantation
- Cannabidiol for Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation
- Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse
- Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease
- GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
- The Effects of Cannabidiol and ∆-9-THC in Humans
- Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
- Cannabidiol for Inflammatory Bowel Disease
- Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
- Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis
- Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia
- Cannabinoids in Bipolar Affective Disorder
- A Clinical Trial on the Antipsychotic Properties of Cannabidiol
- Vaporization as a Smokeless Cannabis Delivery System
Clinical trials list
click for details